Clinical Trials Logo

Clinical Trial Summary

Invasive pulmonary aspergillosis (IPA) is an opportunistic infection that primarily affects recipients of solid organ transplants (SOTs) and patients with chemotherapy- induced neutropenia.Although both of these populations are at high risk for IPA, they differ with regards to the specific defects in host defense mechanisms that increase their risk for IPA. Chemotherapy- induced neutropenia is the principal defect affecting patients with hematologic malignancies, whereas transplant recipients tend to have dysfunctional T cells and phagocytes, as a result of immunosuppressive drug therapy. Thus, the patterns of IPA-related infection and inflammation may differ according to the type of underlying immune defect. Although the clinical and radiological features of IPA in patients with neutropenia have been extensively studied, little is known about the characteristics of IPA in SOT recipients. The investigators therefore compared the IPA- related clinical and radiological findings in SOT recipients with those of neutropenic patients.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01178177
Study type Observational
Source Asan Medical Center
Contact
Status Completed
Phase N/A
Start date January 2008
Completion date February 2010

See also
  Status Clinical Trial Phase
Completed NCT00484848 - Functional Evaluation of Two Types of Totally Implanted Venous Ports N/A
Completed NCT00507533 - Early Application of CPAP in Hematologic Phase 4
Completed NCT00168090 - Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) Phase 4
Recruiting NCT03920735 - Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients
Completed NCT00001749 - Medical Treatment for Diamond Blackfan Anemia Phase 2
Completed NCT03013439 - Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Phase 1
Completed NCT00994136 - Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters Phase 4
Completed NCT00111215 - Treatment and Management of Women With Bleeding Disorders N/A
Completed NCT00586521 - BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Phase 4
Completed NCT00782470 - Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A N/A
Completed NCT00001715 - Evaluation of Patients With Blood Disorders
Completed NCT01426295 - Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital Phase 2
Completed NCT01220011 - Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery N/A